Farmson Basic Drugs Welcomes the Future-Transfer of Pharmaceuticals Manufacturing Business

Farmson Basic Drugs Pvt. Ltd. Welcomes the Future: Transfer of Pharmaceuticals Manufacturing Business

Posted by

Farmson Basic Drugs Pvt. Ltd. is excited to announce a significant development in our business operations that will set the stage for future growth and innovation. Effective from March 26, 2024, the entire pharmaceuticals manufacturing business of Farmson Pharmaceutical Gujarat Pvt. Ltd. (FPGPL) has been transferred to Farmson Basic Drugs Pvt. Ltd. This strategic move comes as a result of Scheme of Demerger, approved by the Regional Director, North-Western Region, Ministry of Corporate Affairs, Ahmedabad, India, as per Order No. RD/NWR/Sec.233/45/2023-24/5111-12, dated March 13, 2024.

Why the Change?

This transition is a step forward in our ongoing commitment to streamline our operations and enhance our capabilities in the pharmaceutical sector. By consolidating our manufacturing operations under Farmson Basic Drugs Pvt. Ltd., we aim to bring greater focus and efficiency to our production processes. This structural change allows us to enhance operational efficiencies and flexibility and bring better value to the stakeholders.

What This Means for Our Stakeholders

For our valued customers, suppliers, and partners, this transition will be seamless. All existing contracts, agreements, and business operations will continue as usual, with no interruption in services or supply chains. Our commitment to delivering high-quality pharmaceutical products remains unwavering. This reorganization is purely operational and is intended to improve our service delivery and production efficiency.

Looking Ahead

The transfer of the pharmaceuticals manufacturing business is not just a restructuring; it’s a strategic move aimed at strengthening our position in the industry. Farmson Basic Drugs Pvt. Ltd. will continue to uphold the legacy of excellence established by Farmson Pharmaceutical Gujarat Pvt. Ltd. and will build upon it to explore new opportunities in pharmaceutical manufacturing and innovation. Our team is fully committed to ensuring that this transition brings positive outcomes for everyone involved.

We are confident that this change will provide us with the foundation to achieve greater heights in the pharmaceutical industry. We thank all our stakeholders for their continued support and trust in Farmson. As we embark on this new chapter, we look forward to working together to create a healthier and brighter future.

Stay tuned for more updates as we continue to innovate and excel!